Cargando…

Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection

Outpatient parenteral antimicrobial therapy (OPAT) is a cost-effective method of administering intravenous antimicrobial therapy. Although OPAT is well established in the UK and US healthcare systems, few centres in Europe perform it. Here we analysed OPAT for the treatment of patients with spinal i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilinc, Fatma, Setzer, Matthias, Behmanesh, Bedjan, Jussen, Daniel, Gessler, Florian, Keil, Fee, Kempf, Volkhard A. J., Kessel, Johanna, Czabanka, Marcus, Prinz, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133347/
https://www.ncbi.nlm.nih.gov/pubmed/37100824
http://dx.doi.org/10.1038/s41598-023-33502-7
_version_ 1785031550059937792
author Kilinc, Fatma
Setzer, Matthias
Behmanesh, Bedjan
Jussen, Daniel
Gessler, Florian
Keil, Fee
Kempf, Volkhard A. J.
Kessel, Johanna
Czabanka, Marcus
Prinz, Vincent
author_facet Kilinc, Fatma
Setzer, Matthias
Behmanesh, Bedjan
Jussen, Daniel
Gessler, Florian
Keil, Fee
Kempf, Volkhard A. J.
Kessel, Johanna
Czabanka, Marcus
Prinz, Vincent
author_sort Kilinc, Fatma
collection PubMed
description Outpatient parenteral antimicrobial therapy (OPAT) is a cost-effective method of administering intravenous antimicrobial therapy. Although OPAT is well established in the UK and US healthcare systems, few centres in Europe perform it. Here we analysed OPAT for the treatment of patients with spinal infections at our institution. In this retrospective study, patients with spinal infection who required intravenous (i.v.) antimicrobial treatment between 2018 and 2021 were analysed. The duration of short-term antimicrobial treatment for skin and soft tissue infections and complex infections requiring long-term antimicrobial treatment, such as spinal bone or joint infections, were analysed. All patients were discharged with a peripherally inserted central catheter (PICC) line. Prior to discharge, all patients received training in the safe administration of their medications via the PICC line. The duration of OPAT and the rate of readmission after OPAT were analysed. For this study a total of 52 patients who were treated via OPAT due to spinal infections were analyzed. In 35 cases (69.2%) complex spinal infection was reason for i.v. antimicrobial therapy. Surgery was required in 23 of these 35 patients (65.7%). The average hospital stay for these patients was 12 ± 6 days. The remaining 17 patients were treated for an infection of the soft tissue or the skin and hospital stay for these patients was on average 8 ± 4 days. Gram-positive organisms were isolated in 64.4%. Staphylococcus aureus followed by other Staphylococcus species, was the most common detected organism. After discharging i.v. antimicrobial treatment was given for an average of 20 ± 14 days. The duration of antimicrobial treatment for soft tissue was 10.8 ± 8 days, and for complex infections 25.1 ± 18 days. The mean follow-up was 21 ± 14 months. There was one case of readmission due to treatment failure. There were no difficulties encountered in implementing OPAT. OPAT is a feasible and effective option for delivering intravenous antimicrobial therapy to patients with spinal infections who can be managed without hospitalisation. OPAT offers patient-centred treatment at home while avoiding the risks associated with hospitalisation, with high levels of patient satisfaction.
format Online
Article
Text
id pubmed-10133347
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101333472023-04-28 Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection Kilinc, Fatma Setzer, Matthias Behmanesh, Bedjan Jussen, Daniel Gessler, Florian Keil, Fee Kempf, Volkhard A. J. Kessel, Johanna Czabanka, Marcus Prinz, Vincent Sci Rep Article Outpatient parenteral antimicrobial therapy (OPAT) is a cost-effective method of administering intravenous antimicrobial therapy. Although OPAT is well established in the UK and US healthcare systems, few centres in Europe perform it. Here we analysed OPAT for the treatment of patients with spinal infections at our institution. In this retrospective study, patients with spinal infection who required intravenous (i.v.) antimicrobial treatment between 2018 and 2021 were analysed. The duration of short-term antimicrobial treatment for skin and soft tissue infections and complex infections requiring long-term antimicrobial treatment, such as spinal bone or joint infections, were analysed. All patients were discharged with a peripherally inserted central catheter (PICC) line. Prior to discharge, all patients received training in the safe administration of their medications via the PICC line. The duration of OPAT and the rate of readmission after OPAT were analysed. For this study a total of 52 patients who were treated via OPAT due to spinal infections were analyzed. In 35 cases (69.2%) complex spinal infection was reason for i.v. antimicrobial therapy. Surgery was required in 23 of these 35 patients (65.7%). The average hospital stay for these patients was 12 ± 6 days. The remaining 17 patients were treated for an infection of the soft tissue or the skin and hospital stay for these patients was on average 8 ± 4 days. Gram-positive organisms were isolated in 64.4%. Staphylococcus aureus followed by other Staphylococcus species, was the most common detected organism. After discharging i.v. antimicrobial treatment was given for an average of 20 ± 14 days. The duration of antimicrobial treatment for soft tissue was 10.8 ± 8 days, and for complex infections 25.1 ± 18 days. The mean follow-up was 21 ± 14 months. There was one case of readmission due to treatment failure. There were no difficulties encountered in implementing OPAT. OPAT is a feasible and effective option for delivering intravenous antimicrobial therapy to patients with spinal infections who can be managed without hospitalisation. OPAT offers patient-centred treatment at home while avoiding the risks associated with hospitalisation, with high levels of patient satisfaction. Nature Publishing Group UK 2023-04-26 /pmc/articles/PMC10133347/ /pubmed/37100824 http://dx.doi.org/10.1038/s41598-023-33502-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kilinc, Fatma
Setzer, Matthias
Behmanesh, Bedjan
Jussen, Daniel
Gessler, Florian
Keil, Fee
Kempf, Volkhard A. J.
Kessel, Johanna
Czabanka, Marcus
Prinz, Vincent
Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
title Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
title_full Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
title_fullStr Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
title_full_unstemmed Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
title_short Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
title_sort safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133347/
https://www.ncbi.nlm.nih.gov/pubmed/37100824
http://dx.doi.org/10.1038/s41598-023-33502-7
work_keys_str_mv AT kilincfatma safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT setzermatthias safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT behmaneshbedjan safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT jussendaniel safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT gesslerflorian safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT keilfee safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT kempfvolkhardaj safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT kesseljohanna safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT czabankamarcus safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection
AT prinzvincent safetyandfeasibilityofoutpatientparenteralantimicrobialtherapyforpatientswithspinalinfection